Italian regulatory authorities have cited two Indian drugmakers for dozens of GMP issues, ranging from data security to quality management issues.
Source: International Pharmaceutical Regulatory Monitor
Italian regulatory authorities have cited two Indian drugmakers for dozens of GMP issues, ranging from data security to quality management issues.
Source: International Pharmaceutical Regulatory Monitor